Development of GLUT4-selective antagonists for multiple myeloma therapy

Cancer cells consume more glucose to fuel metabolic programs fundamental to sustaining their survival, growth and proliferation. Among the fourteen SLC2A family members, GLUTs 1 and 4 are high-affinity glucose transporters. GLUT4 (SLC2A4) is highly expressed in muscle and adipose tissue. Basally ret...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Med Chem
Glavni autori: Wei, Changyong, Bajpai, Richa, Sharma, Horrick, Heitmeier, Monique, Jain, Atul D., Matulis, Shannon M., Nooka, Ajay K., Mishra, Rama K., Hruz, Paul W., Schiltz, Gary E., Shanmugam, Mala
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5603412/
https://ncbi.nlm.nih.gov/pubmed/28837922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2017.08.029
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items